Staff20192020202120222023
Personnel at the end of the year7,3947,5557,6647,7717,604
Staff turnover in EUR556,817624,973782,692972,806876,933
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20192020202120222023
Shares outstanding (in mn.)73,016.0073,202.0073,202.001,645.3873,202.00
Dividend per share140105767840
Basic earnings per share95.95130.66184.29227.64197.83
P/L in EUR million under IAS/IFRS20192020202120222023
Turnover686,184.0786,945.0999,758.01,259,946.01,111,367.0
Operating income (EBIT)1,247.41,788.82,515.63,186.32,652.8
Earnings before taxes207,893.0298,188.0419,385.0531,166.0443,821.0
Annual net profit/ loss157,560.0214,733.0302,995.0374,429.0325,472.0
Balance sheet in EUR million under IAS/IFRS20192020202120222023
Assets
Total current assets699,680.0834,906.01,063,661.01,336,537.01,366,426.0
Total fixed assets359,235.0400,592.0475,033.0533,221.0566,121.0
Total assets1,058,915.01,235,498.01,538,694.01,869,758.01,932,547.0
Liabilities
Total short-term liabilities179,268.0236,070.0327,422.0423,730.0288,217.0
Total long-term liabilities25,661.019,424.023,255.021,641.018,749.0
Total provisions9,442.04,424.05,046.06,067.05,739.0
Equity capital853,985.0980,003.01,188,017.01,424,387.01,625,580.0
Total liabilities1,058,915.01,235,498.01,538,694.01,869,758.01,932,547.0
Management:
Osamu Okuda
Hisafumi Yamada
Junichi Ebihara
Satoko Shisai
Shinji Hidaka
Tetsuya Yamaguchi
Toshiaki Itagaki
Yoshiyuki Yano
Board:
Christoph Franz
James Sabry
Iwaaki Taniguchi
Mariko Momoi
Masayuki Oku
Motoo Ueno
William Anderson
Yoichiro Ichimaru
Shareholding in %:
Address: Nihonbashi Mitsui Tower, 15/F, 2-1-1 Nihonbashi-Muromachi, 103-8324 Tokyo
T: +81-3-3281-6611
F: +81-3-3281-6607
I: http://www.chugai-pharm.co.jp
E: